Compare Dynatrace Inc. Common Stock (DT) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dynatrace Inc. Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Dynatrace Inc. Common Stock trades at $63.38 (market cap $17.66B), while Halozyme Therapeutics Inc. Common Stock trades at $112.16 (market cap $12.58B). The key difference: Dynatrace Inc. Common Stock is the larger of the two by market cap, and Dynatrace Inc. Common Stock is trading nearer its 52-week high, Halozyme Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Dynatrace Inc. Common Stock for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| DT | HALO | |
|---|---|---|
Market Cap | $17.66B | $12.58B |
Volume | 8,779,681 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $61.12 | $115.22 |
52-Week Low | $32.36 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $16.71B | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Dynatrace Inc. Common Stock
Dynatrace provides an observability, security, and automation platform for cloud and IT environments. Its platform integrates data such as logs, metrics, and traces to help organizations monitor digital systems.
Read more on DT →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
